Lipid Dysregulation in Normal Tissues Following Cancer Therapy: Implications for Toxicity and Treatment Resistance

Introduction: This study explores a significant issue within the chosen field, providing a comprehensive overview of current challenges and recent developments. By analyzing relevant literature and existing data, the research aims to identify knowledge gaps and propose potential solutions. The importance of this topic is underscored by its impact on both theoretical understanding and practical applications. Through carefully designed methods, the study seeks to contribute valuable insights and advance ongoing discussions. The findings will inform future research directions and support evidence-based decision-making in this area.

Methods: We developed an integrated imaging and histologic approach to quantify intra-renal non-adipose tissue (IRNAT) lipid accumulation and to examine its association with normal tissue toxicity and tumor response. Non-contrast whole-body MRI was combined with Oil Red O lipid staining for spatial validation to monitor lipid changes following clinically relevant radiation and chemoradiotherapy longitudinally. Studies were performed in mouse models with follow-up up to 40 weeks. Renal and salivary gland injury, inflammation, fibrosis, cholesterol accumulation, and tumor response were evaluated in parallel, and lipid-modulating interventions were tested.

Results: Cancer treatment induced progressive accumulation of non-adipose lipids in the kidney and salivary glands, detectable by MRI and confirmed histologically. Increased IRNAT lipid burden correlated with tubular and glomerular injury, inflammatory remodeling, fibrosis, and functional decline. Elevated lipid dysregulation in normal tissues was also associated with reduced tumor sensitivity and treatment resistance. Targeting lipid pathways mitigated normal tissue injury and improved therapeutic responsiveness.

Conclusions: These findings identify lipid dysregulation as a mechanistic link between cancer, normal tissue toxicity, and treatment resistance. This MRI-based approach provides a practical, non-invasive strategy to quantify lipid changes in both normal tissues and tumors, with potential to enable early prediction of toxicity risk and resistance and to inform treatment planning that balances tumor control with normal tissue protection.